Caracterización clínico-epidemiológica de pacientes con diabetes mellitus tipo 2 y microalbuminuria

Introducción: La diabetes mellitus constituye una enfermedad de elevada morbilidad y mortalidad. Objetivo: Caracterizar clínica y epidemiológicamente la diabetes mellitus tipo 2 y el uso de la microalbuminuria en el daño renal precoz. Materiales y métodos: Se realizó un estudio transversal mediante una muestra no probabilística de 94 pacientes, en un universo de 187 enfermos con diabetes mellitus 2, en el Servicio de Medicina Interna del Hospital Clínico Quirúrgico Docente Amalia Simoni, de Camagüey. El mismo tuvo lugar entre enero de 2020 y enero de 2021. Se analizaron variables como edad, sexo, hábitos tóxicos, estado nutricional, tiempo de evolución de la diabetes, comorbilidades, valor de la microalbuminuria y su relación con el tiempo de evolución de la enfermedad. Para el procesamiento de los datos se empleó el programa estadístico SPSS 19.0. Resultados: Prevalecieron el grupo de 60 años y más, el sexo femenino, el tabaquismo como hábito tóxico, y el sobrepeso. Según el tiempo de evolución de la enfermedad, prevaleció el rango de 6 a 10 años. Las comorbilidades principales fueron la hipertensión arterial y la cardiopatía isquémica. La relación entre el tiempo de evolución de la enfermedad y la aparición de microalbuminuria patológica, demostró la utilidad de esta en la detección del daño renal precoz en pacientes con 6 a 10 años de evolución. Conclusiones: Se demostró el papel de la microalbuminuria en la detección del daño renal precoz en pacientes con diabetes mellitus tipo 2.

Introduction: Diabetes mellitus is a disease with high morbidity and mortality. Objective: To characterize clinically and epidemiologically type 2 diabetes mellitus and the use of microalbuminuria in early kidney damage. Materials and methods: A cross-sectional study was carried out using a non-probabilistic sample of 94 patients from a universe of 187 patients with type2 diabetes mellitus treated in the Internal Medicine Service of the Teaching Clinical-Surgery Hospital "Amalia Simoni", of Camagüey. It was conducted between January 2020 and January 2021. Variables such as age, sex, toxic habits, nutritional status, time of evolution of diabetes, comorbidities; value of albuminuria and its relationship with the time of evolution of the disease were analyzed. The SPSS 19.0 statistical program was used for data processing. Results: The age group of 60 years old and over, female sex, smoking as a toxic habit, and overweight prevailed. According to the time of evolution of the disease, the range of 6 to 10 years prevailed. The main comorbidities were arterial hypertension and ischemic heart disease. The relationship between the time of evolution of the disease and the appearance of pathological microalbuminuria demonstrated its usefulness in the detection of early kidney damage in patients with 6 to 10 years of evolution. Conclusions: The role of microalbuminuria in the detection of early kidney damage in patients with type 2 diabetes mellitus was demonstrated.

Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol

Introduction:Metabolic syndrome (MetS) predicts cardiovascular disease, and patients with this condition and type 2 diabetes have increased albuminuria, significantly impacting cardiovascular mortality and kidney disease progression. A considerable number of interventions to control MetS exist and are considered efficient, including the use of medication and changes in lifestyle. However, which approaches are effective in controlling albuminuria remains unclear. This systematic review protocol aims to map in the available literature whether lifestyle, medication, and surgical intervention for MetS have an impact on reducing albuminuria in adult patients. Methods: The Joanna Briggs Institute methodology for systematic reviews will be followed. Cochrane Database of Systematic Reviews, Scopus, Embase, and MEDLINE/PubMed databases will be used. For the Gray Literature, the DART-Europe E-theses Portal. There will be no language restriction. Studies written after 2009 will be included due to the consensus and definition of metabolic syndrome. This review will include studies considering pharmacological and non-pharmacological treatments for controlling albuminuria in patients with MetS. Studies where MetS is described in children and adolescents, animals, pregnant women, and patients with type 1 diabetes will be excluded. First, the selection will be based on reading the title and summary of the texts retrieved in the search strategy, followed by reading the relevant texts in full by two reviewers. After the selection of the studies, the extraction of the data, analysis, and synthesis will be conducted according to the JBI methodology

Biomarcadores tempranos en nefropatia diabética / Early biomarkers in diabetic nephropathy

La enfermedad renal diabética es una patología de presentación frecuente y una costosa complicación de la diabetes. Se considera una de las principales causas de insuficiencia renal e ingreso a Terapia de Reemplazo renal. En la práctica clínica, la enfermedad renal diabética se diagnostica por albuminuria, una disminución de la tasa de filtración glomerular estimada (eGFR), o ambos. Actualmente existe la posibilidad de detectar varios marcadores tempranos, como el CKD273, el mismo que se asoció con un mayor riesgo de progresión a microalbuminuria, siendo una alerta temprana de presentación de nefropatía diabetica, varios años antes de su presentación.

SUMMARY Diabetic kidney disease is a common presenting condition and a costly complication of diabetes. It is considered one of the main causes of renal failure and admission to renal replacement therapy. In clinical practice, diabetic kidney disease is diagnosed by albuminuria, a decrease in estimated glomerular filtration rate (eGFR), or both. Currently, there is the possibility of detecting early markers such as CKD273, which was associated with an increased risk of progression to microalbuminuria, being an early warning of the presentation of diabetic nephropathy, several years before its presentation.

Microalbuminuria y proteína C reactiva ultrasensible como potenciales biomarcadores de inflamación sistémica en pacientes con Enfermedad Pulmonar Obstructiva Crónica

Resumen Si bien aún no hay una definición precisa de inflamación sistémica en EPOC, su reconocimiento se ha basado en estudios que han demostrado un aumento de concentración plasmática de diversos marcadores inflamatorios entre ellos proteína C reactiva (PCR) y, en los últimos años se ha postulado también la microalbuminuria. Los objetivos de este trabajo fueron determinar la microalbuminuria y la PCR como potenciales biomarcadores de inflamación sistémica. Para ello se reclutaron pacientes EPOC estable y tabaquistas no EPOC diagnosticados mediante espirometria, mayores a 40 años sin HTA ni diabetes tipo I ó II, en el periodo comprendido entre octubre de 2017 a marzo de 2019. A ambos grupos se le extrajo una muestra de sangre venosa para determinar PCR ultrasensible y 3 muestras de orina para determinar microalbuminuria, tomando una media de las mismas. Se consideró albuminuria significativa cuando en al menos dos de tres determinaciones hubiese valores entre 30 y 300 mg/g de creatinina urinaria. La PCR ultrasensible se consideró positiva con un valor igual o superior a 5 mg/L. De los 47 pacientes analizados se obtuvo una albuminuria media de 13.91 ± 5.04 en el grupo EPOC en comparación con 2.50 ± 0.36 del grupo control. De la misma forma se compararon las medias de PCR ultrasensible, arrojando un valor de 5.06 ± 2.24 en los pacientes EPOC en relación a 2.46 ± 0.51 de los controles. Ambas variables mostraron diferencias estadísticamente no significativas entre los grupos de estudio (p = 0,058 para albuminuria media y p = 0.330 para PCR ultrasensible).

Microalbuminuria and High-Sensitivity C-Reactive Protein as Potential Biomarkers of Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

Abstract There isn't yet a clear definition for systemic inflammation in COPD (chronic obstructive pulmonary disease), but its recognition has been based on studies that show an increase in the plasma concentration of various inflammatory markers, such as the c-reactive protein (CRP), and in recent years, also the microalbuminuria has been suggested. The purposes of this work were to determine the microalbuminuria and CRP as potential biomarkers of systemic inflammation. We enrolled patients with stable COPD and non-COPD smokers diagnosed through spirometry; older than 40 years without AHT (arterial hypertension) or diabetes type I or II, between October 2017 and March 2019. In both groups, a venous blood sample was collected to determine high-sensitivity CRP and 3 urine samples were taken to determine microalbuminuria, calculating the mean value. At least two out of three determinations between 30 and 300 mg/g of urine creatinine were considered to be significant albuminuria. The high-sensitivity CRP was considered positive with a value ≥ 5 mg/L. Of the 47 analyzed patients, a mean albuminuria of 13.91 ± 5.04 was obtained in the COPD group, in comparison with 2.50 ± 0.36 in the control group. Also, the high-sensitivity CRP mean values were compared, showing 5.06 ± 2.24 in COPD patients and 2.46 ± 0.51 in the control group. Both variables showed non-statistically significant differences between the study groups (p = 0.058 for mean albuminuria and p = 0.330 for high-sensitivity CRP).

Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control.

OBJECTIVE: Evaluate ferritin levels in children and adolescents with type 1 diabetes mellitus and its relation to diabetic microvascular complications, and metabolic control. METHODS: This study included 180 children and adolescents with type 1 diabetes mellitus (T1DM) with a mean age of 14.9 ± 3.1 years and 180 apparently normal children matched for age and sex (control group). All children were evaluated with full history taking, thorough clinical examination, laboratory assessment of high-sensitivity C-reactive protein and hemoglobin A1c (HbA1c), and evaluation of the presence of microvascular complications. Serum ferritin levels were measured using electrochemiluminescence immunoassay. The patients were divided into two groups according to the presence or absence of microvascular complications. RESULTS: Serum ferritin levels were significantly higher in patients with T1DM in both groups compared with healthy controls (p < 0.001). Additionally, patients with microvascular complications had higher serum ferritin concentrations than those without microvascular complications (p < 0.001). Patients with microalbuminuria showed higher ferritin levels compared with patients without microalbuminuria (p < 0.05). Stepwise regression analysis revealed that levels of HbA1c and urinary albumin excretion were independently related to ferritin levels (p < 0.001 for both). On receiver operating characteristic (ROC) curve analysis, a ferritin cutoff value of 163.6 ng/mL differentiated patients with microvascular complications from those without microvascular complications with a sensitivity of 92.1% and specificity of 93.4%. CONCLUSION: Serum ferritin levels are elevated in T1DM, particularly in patients with microvascular complications.

Comparação entre os resultados da urinálise e dosagens bioquímicas urinárias de amostras de urina coletadas pelas técnicas de cistocentese guiada por ultrassom e sondagem uretral em cães / Comparison between the results of urinalysis and urinary biochemical tests of urine samples collected by techniques ultrasound-guided cystocentesisand urethral catheterization in dogs

Objetivou-se no presente estudo comparar as técnicas de coleta de urina via sondagem uretral e cistocentese guiada por ultrassom, afim de verificar se o método de coleta pode influir nos resultados laboratoriais. Foram utilizados 12 cães machos, sem histórico de enfermidades, dos quais coletou-se cinco mililitros (mL) de urina via sondagem uretral e cinco mL via cistocentese guiada por ultrassom, ambas no mesmo momento. Posteriormente foi realizada a análise física (cor, odor, densidade, turbidez), química (urobilinogênio, glicose, corpos cetônicos, bilirrubina, proteína, nitrito, pH, sangue e leucócitos) e sedimentoscopia (avaliação de 10 campos de luz, objetiva de 40x). Cilindros urinários, cristais, corpúsculos gordurosos, espermatozoides, bactérias e células vesicais foram classificados qualitativamente como: ausentes (0), discretos (1), moderados (2) e intensos (3). Hemácias, leucócitos, e células de descamação foram quantificadas a partir da média dos campos analisados. As análises bioquímicas de microalbuminúria, creatinina e proteína total urinárias foram realizadas a partir do sobrenadante urinário, removido das amostras após centrifugação, e utilizados kits reagentes, conforme recomendação do fabricante, sendo a leitura em espectrofotômetro. Em todos os testes realizados os valores de p encontrados foram superiores 0,05 (p>0,05), excluindo-se a possibilidade de haver diferenças significativas dos resultados laboratoriais obtidos pelas duas formas de coleta.

The objective of this study was to compare two techniques of urine collection, urethral catheterization and ultrasound-guided cystocentesis, in order to verify if the collection method may influence the laboratory results. Twelve male dogs were used, with no history of diseases, of which five milliliters (mL) of urine were collected by urethral catheterization and five mL by both at the same time. Subsequently, the samples underwent physical analysis (color, smell, density andturbidity), chemical analysis (urobilinogen, glucose, ketone bodies, bilirubin, protein, nitrite, pH, blood and leukocytes) and sedimentoscopy (evaluation of 10 light fields, 40x objective). Urinary casts, fatty corpuscles, spermatozoa, bacteria and bladder epithelial cells were classified qualitatively as absent (0), discrete (1), moderate (2) and intense (3). Red blood cells, leukocytes and desquamation cells were quantified from the mean of the analyzed fields. The urine supernatants were obtained after centrifugation and were used for biochemical analyzes of microalbuminuria, urinary protein and creatinine. The reagent kits were used as recommended by the manufacturer and the samples were read by spectrophotometry. All tests presented p values higher than 0,05 (p>0,05), excluding the possibility of significant differences between the laboratory results of both forms of urine collection.

Comparação entre os resultados da urinálise e dosagens bioquímicas urinárias de amostras de urina coletadas pelas técnicas de cistocentese guiada por ultrassom e sondagem uretral em cães / Comparison between the results of urinalysis and urinary biochemical tests of urine samples collected by techniques ultrasound-guided cystocentesisand urethral catheterization in dogs

Objetivou-se no presente estudo comparar as técnicas de coleta de urina via sondagem uretral e cistocentese guiada por ultrassom, afim de verificar se o método de coleta pode influir nos resultados laboratoriais. Foram utilizados 12 cães machos, sem histórico de enfermidades, dos quais coletou-se cinco mililitros (mL) de urina via sondagem uretral e cinco mL via cistocentese guiada por ultrassom, ambas no mesmo momento. Posteriormente foi realizada a análise física (cor, odor, densidade, turbidez), química (urobilinogênio, glicose, corpos cetônicos, bilirrubina, proteína, nitrito, pH, sangue e leucócitos) e sedimentoscopia (avaliação de 10 campos de luz, objetiva de 40x). Cilindros urinários, cristais, corpúsculos gordurosos, espermatozoides, bactérias e células vesicais foram classificados qualitativamente como: ausentes (0), discretos (1), moderados (2) e intensos (3). Hemácias, leucócitos, e células de descamação foram quantificadas a partir da média dos campos analisados. As análises bioquímicas de microalbuminúria, creatinina e proteína total urinárias foram realizadas a partir do sobrenadante urinário, removido das amostras após centrifugação, e utilizados kits reagentes, conforme recomendação do fabricante, sendo a leitura em espectrofotômetro. Em todos os testes realizados os valores de p encontrados foram superiores 0,05 (p>0,05), excluindo-se a possibilidade de haver diferenças significativas dos resultados laboratoriais obtidos pelas duas formas de coleta.

The objective of this study was to compare two techniques of urine collection, urethral catheterization and ultrasound-guided cystocentesis, in order to verify if the collection method may influence the laboratory results. Twelve male dogs were used, with no history of diseases, of which five milliliters (mL) of urine were collected by urethral catheterization and five mL by both at the same time. Subsequently, the samples underwent physical analysis (color, smell, density andturbidity), chemical analysis (urobilinogen, glucose, ketone bodies, bilirubin, protein, nitrite, pH, blood and leukocytes) and sedimentoscopy (evaluation of 10 light fields, 40x objective). Urinary casts, fatty corpuscles, spermatozoa, bacteria and bladder epithelial cells were classified qualitatively as absent (0), discrete (1), moderate (2) and intense (3). Red blood cells, leukocytes and desquamation cells were quantified from the mean of the analyzed fields. The urine supernatants were obtained after centrifugation and were used for biochemical analyzes of microalbuminuria, urinary protein and creatinine. The reagent kits were used as recommended by the manufacturer and the samples were read by spectrophotometry. All tests presented p values higher than 0,05 (p>0,05), excluding the possibility of significant differences between the laboratory results of both forms of urine collection.

Microalbuminuria as a potential biomarker for Parkinson's disease severity: A hypothesis.

Parkinson's disease (PD) is the second most common neurodegenerative condition characterized by motor and non-motor symptoms causing a great burden in patients' quality of life. PD has been associated with various metabolic factors such as diabetes, hypertension, and more recently chronic kidney disease where proteinuria has been associated with an increased risk. The presence of small amounts of albumin in urine, microalbuminuria, is a common biomarker for endothelial damage and a predictive factor for not only cardiovascular but also neurological dysfunction. Multiple studies have assessed potential biomarkers for PD progression with great heterogeneity, we hypothesize the use of microalbuminuria as a potential marker that correlates with PD severity and might represent a feasible and simple method of evaluating PD patients in clinical practice. Evidence supporting the present hypothesis comes from oxidative stress, insulin resistance, and endothelial dysfunction. Oxidative stress is a key element in PD pathogenesis; studies have shown lower antioxidant capacity as PD progresses. On the other side, insulin signaling plays an important role in neuronal growth and survival, with its resistance being associated with PD. Microalbuminuria has been associated with both processes; increased levels of oxidative stress markers and decreased insulin sensitivity, hence its screening in PD might reflect these common pathological mechanisms. Moreover, the low vitamin D levels observed in PD patients, which are correlated with endothelial dysfunction and disease severity, might contribute to microalbuminuria induction. More evidence on this vascular approach comes from white matter lesions (WML), observed in brain imaging, which have been significantly associated with motor and non-motor function in PD patients and are independently associated with microalbuminuria. In this manner, an oxidant and insulin resistant environment, along with low vitamin D levels in PD patients, which are associated with microalbuminuria, might contribute altogether to WML. As the latter are correlated with motor and non-motor function, microalbuminuria might thus give insight on PD status. Prospective cohort studies with an adequate sample size, follow-up, and a thorough battery of clinical tests for PD are needed to confirm this hypothesis.

Comparação entre os resultados da urinálise e dosagens bioquímicas urinárias de amostras de urina coletadas pelas técnicas de cistocentese guiada por ultrassom e sondagem uretral em cães / Comparison between the results of urinalysis and urinary biochemical tests of urine samples collected by techniques ultrasound-guided cystocentesisand urethral catheterization in dogs

Objetivou-se no presente estudo comparar as técnicas de coleta de urina via sondagem uretral e cistocentese guiada por ultrassom, afim de verificar se o método de coleta pode influir nos resultados laboratoriais. Foram utilizados 12 cães machos, sem histórico de enfermidades, dos quais coletou-se cinco mililitros (mL) de urina via sondagem uretral e cinco mL via cistocentese guiada por ultrassom, ambas no mesmo momento. Posteriormente foi realizada a análise física (cor, odor, densidade, turbidez), química (urobilinogênio, glicose, corpos cetônicos, bilirrubina, proteína, nitrito, pH, sangue e leucócitos) e sedimentoscopia (avaliação de 10 campos de luz, objetiva de 40x). Cilindros urinários, cristais, corpúsculos gordurosos, espermatozoides, bactérias e células vesicais foram classificados qualitativamente como: ausentes (0), discretos (1), moderados (2) e intensos (3). Hemácias, leucócitos, e células de descamação foram quantificadas a partir da média dos campos analisados. As análises bioquímicas de microalbuminúria, creatinina e proteína total urinárias foram realizadas a partir do sobrenadante urinário, removido das amostras após centrifugação, e utilizados kits reagentes, conforme recomendação do fabricante, sendo a leitura em espectrofotômetro. Em todos os testes realizados os valores de p encontrados foram superiores 0,05 (p>0,05), excluindo-se a possibilidade de haver diferenças significativas dos resultados laboratoriais obtidos pelas duas formas de coleta.(AU)

The objective of this study was to compare two techniques of urine collection, urethral catheterization and ultrasound-guided cystocentesis, in order to verify if the collection method may influence the laboratory results. Twelve male dogs were used, with no history of diseases, of which five milliliters (mL) of urine were collected by urethral catheterization and five mL by both at the same time. Subsequently, the samples underwent physical analysis (color, smell, density andturbidity), chemical analysis (urobilinogen, glucose, ketone bodies, bilirubin, protein, nitrite, pH, blood and leukocytes) and sedimentoscopy (evaluation of 10 light fields, 40x objective). Urinary casts, fatty corpuscles, spermatozoa, bacteria and bladder epithelial cells were classified qualitatively as absent (0), discrete (1), moderate (2) and intense (3). Red blood cells, leukocytes and desquamation cells were quantified from the mean of the analyzed fields. The urine supernatants were obtained after centrifugation and were used for biochemical analyzes of microalbuminuria, urinary protein and creatinine. The reagent kits were used as recommended by the manufacturer and the samples were read by spectrophotometry. All tests presented p values higher than 0,05 (p>0,05), excluding the possibility of significant differences between the laboratory results of both forms of urine collection.(AU)

Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control

ABSTRACT Objective: Evaluate ferritin levels in children and adolescents with type 1 diabetes mellitus and its relation to diabetic microvascular complications, and metabolic control. Subjects and methods: This study included 180 children and adolescents with type 1 diabetes mellitus (T1DM) with a mean age of 14.9 ± 3.1 years and 180 apparently normal children matched for age and sex (control group). All children were evaluated with full history taking, thorough clinical examination, laboratory assessment of high-sensitivity C-reactive protein and hemoglobin A1c (HbA1c), and evaluation of the presence of microvascular complications. Serum ferritin levels were measured using electrochemiluminescence immunoassay. The patients were divided into two groups according to the presence or absence of microvascular complications. Results: Serum ferritin levels were significantly higher in patients with T1DM in both groups compared with healthy controls (p < 0.001). Additionally, patients with microvascular complications had higher serum ferritin concentrations than those without microvascular complications (p < 0.001). Patients with microalbuminuria showed higher ferritin levels compared with patients without microalbuminuria (p < 0.05). Stepwise regression analysis revealed that levels of HbA1c and urinary albumin excretion were independently related to ferritin levels (p < 0.001 for both). On receiver operating characteristic (ROC) curve analysis, a ferritin cutoff value of 163.6 ng/mL differentiated patients with microvascular complications from those without microvascular complications with a sensitivity of 92.1% and specificity of 93.4%. Conclusion: Serum ferritin levels are elevated in T1DM, particularly in patients with microvascular complications.

An enzyme immunoassay for determining albumin in human urine samples using an ultra-microanalytical system.

Microalbuminuria is a term to describe a moderate increase in the level of albumin in urine. It is an important prognostic marker for kidney damage in diseases such as diabetes mellitus and hypertension. A simple sandwich-type ultramicroELISA assay (UMELISA) has been developed for the measurement of albumin in human urine samples. Strips coated with a high affinity monoclonal antibody directed against albumin are used as solid phase, to ensure the specificity of the assay. The albumin assay was completed in 1 hr and 30 min, with a measuring range of 1.44-200 ng/mL. The intra- and inter-assay coefficients of variation were 3.98-4.35% and 7.59-8.92%, respectively, depending on the albumin concentrations evaluated. Percentage recovery ranged from 94.26 to 98.50%. Regression analysis showed a good correlation with the commercial quantitative turbidimetric test Microalbumin-turbilatex (n = 240, r = 0.994, p < .01). The analytical performance characteristics of our UMELISA MICROALBUMINA endorse its use for the quantification of albumin in human urine samples. This test will make a cost-effective diagnostic kit accessible to low-income countries such as Latin American countries and is now available in the Cuban Public Health System.

Monitoring cellulose oxidation for protein immobilization in paper-based low-cost biosensors.

The oxidation of paper by periodate was investigated and systematically characterized by Fourier-transform infrared (FTIR) spectroscopy, scanning electron microscopy, X-ray diffraction, goniometry, and dynamic mechanical analysis. For the first time, in situ FTIR microscopy analysis was performed, yielding chemical images of carbonyl groups on the cellulose fibers. The enhancement of protein immobilization on oxidized paper was quantified by a colorimetric assay with Ponceau dye, demonstrating that 0.5-h oxidation suffices to functionalize the paper-based devices. The oxidized paper was applied as a sensor for protein quantification in urine, a test able to detect levels of proteinuria and even microalbuminuria. The quantification was based on the capture of proteins through covalent bonds formed with the carbonyl groups on the oxidized paper followed by the staining of the region with Ponceau dye. There is a linear dependency between human serum albumin (HSA) concentration and the length of the stained blot from 0.1 to 3 mg mL-1. This method correlated linearly with a reference method showing a higher sensitivity (0.866 cm mL mg-1) than the latter. The limit of quantification was 0.1 mg mL-1, three times lower than that of the commercial strip. Graphical abstract Paper oxidation with periodate and extensive characterization, including microspectroscopy. The conversion of cellulose hydroxyl groups to aldehyde enhances covalent immobilization of protein on paper for application as analytical device. The oxidized paper determined protein in urine, suitable for proteinuria diagnosis.

Microalbuminuria y proteína C reactiva como índices de riesgo cardiovascular en pacientes con síndrome metabólico / Microalbuminuria and C reactive protein as cardiovascular risk indices in patients with metabolic syndrome

Se realizó una investigación cuantitativa de tipo correlacional con el objeto de evaluar la asociación entre microalbuminuria (MA), proteína C reactiva ultrasensible (PCR-us) y riesgo cardiovascular (RCV) de acuerdo a la escala de Framingham en pacientes con síndrome metabólico (SM) que asistieron a la consulta del Servicio de Medicina Interna del Hospital Universitario Dr. Luis Gómez López durante el período junio 2017-junio 2018. La muestra la conformaron 30 pacientes con una edad promedio de 49,53 ± 13,35 años y predominio del sexo femenino. El 53,3% de los pacientes no tenía tratamiento. El 73,3% de los pacientes presentaron RCV muy alto y alto de acuerdo a la escala de Framingham. La mayor parte de los pacientes con RCV muy alto presentaron valores elevados de PCR-us. Se observó una correlación positiva entre los valores de PCR-us y el RCV (R=0,533, p < 0.05). Es importante la identificación temprana del SM como factor de riesgo para el desarrollo de enfermedades cardiovasculares(AU)

A correlation-type quantitative investigation was carried out with the aim to evaluate the association between microalbuminuria (MA), high-sensitive C-reactive protein (hs-CRP) and cardiovascular risk (CVR) determined by the Framingham scale in patients with Metabolic Syndrome (MS) who attended the Internal Medicine Service of the Hospital Universitario Dr. Luis Gómez López during the period June 2017-June 2018. Thirty patients were included with an average age of 49.53 ± 13.35 years and female sex predominance. According to the Framingham scale, 73.3% of patients had very high and high CVR. Most patients with very high CVR had elevated levels of hs-CRP. There was a positive and significant correlation between hs-CRP levels and CVR (R=0.533, p <0.05). An early diagnosis of MS is important as a risk factor for the development of cardiovascular disease(AU)

Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.

One of the major chronic complications of sickle cell disease (SCD) is sickle cell nephropathy. The aim of this review is to discuss the pathophysiology, natural history, clinical manifestations, risk factors, biomarkers and therapeutic approaches for sickle cell nephropathy, focusing on studies with pediatric patients. The earliest manifestation of renal disease is an increase in the glomerular filtration rate. A finding that may also be observed in early childhood is microalbuminuria. Nephrin, KIM-1, VGFs, chemokines and renin-angiotensin system molecules have emerged as potential early markers of renal dysfunction in SCD. In regards to a therapeutic approach, renin-angiotensin system inhibitors and angiotensin receptor blockers seem to be effective for the control of albuminuria in adults with SCD, although new studies in children are needed. The precise moment to begin renoprotection in SCD patients who should be treated remains to be determined.

Microalbuminuria como marcador de daño renal en pacientes con hipertensión arterial / Microalbuminuria as a marker of kidney damage in patients with arterial hypertension

Introducción: La hipertensión arterial es un poderoso factor de riesgo de daño renal. La prevalencia es muy alta entre los pacientes con Enfermedad Renal Crónica. Objetivo: Determinar la presencia de Microalbuminuria y su valor como marcador de daño renal en pacientes con diagnóstico de Hipertensión arterial. Material y Métodos: Se realizó un estudio descriptivo, longitudinal y prospectivo de 123 pacientes. Se determinó edad, sexo, cifras de colesterol, triglicéridos, creatinina y microalbuminuria y factores de riesgo vascular. Se utilizó la estadística descriptiva e inferencial. Resultados: El 40,7 Microalbuminuria as a marker of kidney damage in patients with arterial hypertension de los pacientes pertenecen al grupo de más de 70 años con predominio del sexo masculino (65 por ciento), 62,6 Microalbuminuria as a marker of kidney damage in patients with arterial hypertension presentaron microalbuminuria, 97,3 Microalbuminuria as a marker of kidney damage in patients with arterial hypertension tenían factores de riesgo asociados con prevalencia aumentada del tabaquismo, dislipidemia, obesidad y enfermedades vasculares asociadas con RP>1. Predominó el grupo mayor de 70 años, del sexo masculino, con presencia de microalbuminuria. La presencia de más de tres factores de riesgo se asoció a la microalbuminuria. La presencia de microalbuminuria aumentó con los años de evolución de la enfermedad. Predominó el estadio 3 de la Enfermedad Renal Crónica en los pacientes con hipertensión arterial y microalbuminuria y se relacionó directamente con los años de evolución de la hipertensión arterial. Conclusiones: La determinación de la microalbuminuria en los pacientes con hipertensión arterial es un marcador de riesgo importante y sencillo para determinar el daño renal subclínico y está muy relacionado con el incremento de la edad del paciente, años de hipertensión y asociación con otros factores de riesgo vasculares(AU)

Introduction: Arterial hypertension is a powerful risk factor for kidney damage. The prevalence is very high among patients with chronic kidney disease. Objective: To determine the presence of microalbuminuria as a marker of kidney damage in patients with arterial hypertension admitted between September 2016 and September 2017. Material and Methods: A descriptive, longitudinal, prospective study was conducted in 123 patients. Age; sex; cholesterol, triglycerides, creatinine and microalbuminuria levels and vascular risk factors were determined. Descriptive and inferential statistics were used. Results: The 40.7 percent of patients belong to the group of patients of age more than 70 years, predominating the male sex (65 percent); 62.6 percent of them presented microalbuminuria and 97.3 percent had risk factors associated with an increased prevalence of smoking, dyslipidemia, obesity, and vascular diseases associated with RP> 1. The group of patients older than 70 years, male, and with presence of microalbuminuria predominated in the study. The presence of more than three risk factors was associated with microalbuminuria. The presence of microalbuminuria increased with the years of evolution of the disease. Stage 3 of chronic kidney disease predominated in patients with arterial hypertension and microalbuminuria and it was directly related to the years of evolution of arterial hypertension. Conclusions: The determination of microalbuminuria in patients with arterial hypertension is a simple and important risk marker to determine subclinical kidney damage and it is closely related to the increase in the age of the patient, the years of hypertension, and the association with other risk factors for vascular disease(AU)

Control y evaluación de la microalbuminuria en una población del estado de Nayarit, México. Estudio realizado mediante la automedición a préstamo de la presión arterial / Control and evaluation of microalbuminuria in a population of the state of Nayarit, Mexico. Study conducted by self-measurement on loan of blood pressure

Resumen: ANTECEDENTES Existen antecedentes de que el control estricto de las cifras de presión arterial puede repercutir favorablemente evitando la aparición de microalbuminuria y, por tanto, previniendo la nefropatía, asimismo, disminuye significativamente los desenlaces fatales por enfermedad cardiovascular y cerebrovascular. OBJETIVO Demostrar que el control estricto de las cifras tensionales puede disminuir la microalbuminuria. MATERIAL Y METODO Estudio observacional y descriptivo efectuado de enero a diciembre de 2017, en el que se evaluaron pacientes con diagnóstico establecido de diabetes mellitus tipo 2, hipertensión arterial sistémica o ambas; la selección fue aleatoria. A estos pacientes se les incorporó en un protocolo de automedición a préstamo de la presión arterial. No se incluyeron pacientes con insuficiencia renal crónica. RESULTADOS Se incluyeron 200 pacientes en quienes se midió la correlación entre múltiples variables y la existencia de microalbuminuria. Se encontró correlación estadísticamente significativa al segmentar a los pacientes según la clasificación de ACC/AHA 2017 y posterior al ajuste de la dosis de antihipertensivo con valor de p = 0.00001. CONCLUSIONES Con estos hallazgos podría plantearse el ajuste del tratamiento con base en las cifras tensionales del paciente, sin importar si el tratamiento es con IECAS o ARA II.

Abstract: BACKGROUND There are precedents that the strict control of the blood pressure figures can have a favorable impact avoiding the development of microalbuminuria, and therefore preventing the appearance of nephropathy, as well as significantly reducing fatal outcomes due to cardiovascular and cerebrovascular disease. OBJECTIVE To show that strict control of tension figures can impact decreasing the microalbuminuria. MATERIAL AND METHOD An observational and descriptive study was done from January to December 2017 with patients with an established diagnosis of type 2 diabetes mellitus and/or systemic hypertension, with random selection. These patients were incorporated into a Self-Commissioning Protocol to loan blood pressure. Patients with chronic kidney disease were not included. RESULTS There were included 200 patients. The correlation between multiple variables and the presence of microalbuminuria was measured finding a statistically significant correlation when segmenting patients according to the ACC/AHA 2017 classification and after adjusting the antihypertensive dose with p = 0.00001. CONCLUSIONS Treatment should be adjusted based on the patient's blood pressure, regardless of whether the treatment is with IECAS or ARA II.

Alteration of Renal Natriuretic Systems Is Associated with the Development of Hypertension and Precedes the Presence of Renal Damage in a Model of Metabolic Syndrome / La alteración de sistemas natriuréticos renales se asocia con el desarrollo de hipertensión arterial y precede en el tiempo a la aparición de daño renal en un modelo de síndrome metabólico

ABSTRACT: Background: The aim of this study was to determine the presence of alterations in the natriuretic systems of atrial natriuretic peptide and renal dopamine in a model of metabolic syndrome induced by fructose overload and to associate them with changes in systolic blood pressure, renal function, Na+/K+-ATPase status and microalbuminuria. Methods: Male Sprague-Dawley rats were divided into control (C) and fructose (F) groups receiving drinking water or a fructose so-lution (10% W/V), respectively, for 4, 8 and 12 weeks. L-dopa and dopamine, sodium, creatinine and albumin were measured in urine and ANP, insulin, sodium and creatinine in plasma. Systolic blood pressure was measured by indirect method and the renal activity and expression of Na+/K+-ATPase as well as the renal expression of A- and C-type natriuretic peptide receptors were assessed. results: Fructose overload was associated with a significant increase in insulinemia and systolic blood pressure levels and a decrease in urinary sodium excretion since week 4. A significant increase in L-dopa excretion and a decrease in dopamine excretion (increased urinary L-dopa/dopamine ratio) due to fructose overload were observed since week 4 with a decrease in plasma atrial natriuretic peptide at weeks 8 and 12. These changes were accompanied by increased activity and expression of Na+/ K+-ATPase, decreased A-type natriuretic peptide receptor and increased C-type natriuretic peptide receptor expression. Microalbuminuria was observed at week 12 of fructose overload.

RESUMEN: Objetivos: El objetivo del trabajo consistió en determinar la existencia de alteraciones en los sistemas natriuréticos del péptido natriurético atrial y dopamina renal en un modelo de síndrome metabólico por sobrecarga de fructosa y asociarlas con cambios en la presión arterial sistólica, función renal, estado de la Na+, K+-ATPasa y microalbuminuria. Material y Métodos: Ratas macho Sprague-Dawley fueron divididas en grupos control (C) y fructosa (F) con agua o solución de F (10%P/V) para beber durante 4, 8 y 12 semanas. En orina, se midió L-dopa y dopamina, sodio, creatinina y albúmina; y en plasma péptido natriurético atrial, insulina, sodio y creatinina. La presión arterial sistólica fue medida por método indirecto. Se midió la actividad y expresión de la Na+, K+-ATPasa así como la expresión del receptor de péptidos natriuréticos A y C renales. resultados: La sobrecarga de fructosa se asoció con el aumento de la insulinemia y la presión arterial sistólica, y con la disminución en la excreción urinaria de sodio desde la semana 4. La excreción urinaria de L-dopa se incrementó y la de dopamina disminuyó (cociente L-dopa/dopamina incrementado) por sobrecarga de fructosa desde la semana 4 y el péptido natriurético atrial plasmático se redujo en las semanas 8 y 12. Estos cambios fueron acompañados por un incremento de la actividad y expresión de la Na+, K+-ATPasa, disminución del receptor de péptidos natriuréticos A y aumento del C. La microalbuminuria se observó en la semana 12 de sobrecarga de fructosa. Conclusiones: Las alteraciones del péptido natriurético atrial y de la dopamina renal se asociaron con el desarrollo de hipertensión arterial y precedieron a la aparición de microalbuminuria, por lo que se pudo establecer una asociación temporal entre la alteración de ambos sistemas y el desarrollo de daño renal.

Aspectos clínicos y epidemiológicos relacionados con la microalbuminuria en pacientes con diabetes mellitus de tipo 2 / Clinical and epidemiological aspects related to microalbuminuria in patients with type 2 diabetes mellitus

Se realizó un estudio observacional, descriptivo, de serie de casos, para determinar la presencia de microalbuminuria en pacientes con diabetes mellitus de tipo 2, dispensarizados en el consultorio médico No. 42 del Policlínico Docente José Martí Pérez de Santiago de Cuba, desde octubre de 2016 hasta igual mes de 2017. En la serie, el grupo etario de mayor connotación epidemiológica, relacionado con la microalbuminuria de rango elevado, resultó ser el de 60-64 años (86,7 por ciento). El tiempo de evolución de la diabetes estuvo estrechamente vinculado con la detección de microalbuminuria elevada; asimismo, los diferentes estadios de la enfermedad renal crónica guardaron relación con el tiempo de evolución de la enfermedad, es decir, el estadio 1 se correspondió con el inicio de la diabetes y los estadios 4 y 5 con los enfermos con más de 10 años de evolución. Se evidenció la importancia del estudio de la microalbuminuria en enfermos con pocos años de evolución de la enfermedad(AU)

An observational, descriptive and serial cases study, to determine the presence of microalbuminuria in 80 patients with type 2 diabetes mellitus, classified in the doctor's office No. 42 of José Martí Pérez Teaching Polyclinic was carried out in Santiago de Cuba, from October, 2016 to the same month in 2017. In the series, the 60-64 age group was the one with higher epidemiological connotation, related to the microalbuminuria of high range (86.7 percent). The course time of the diabetes was closely linked with the detection of high microalbuminuria; also, the different stages of the chronic renal disease bore no relation with the course time of the illness, that is to say, the stage 1 was in correspondence with the beginning of the diabetes and the stages 4 and 5 with the patients with more than 10 years of clinical course. The importance of studying the microalbuminuria was evidenced in patients with few years of the disease course(AU)

Aspectos clínicos y epidemiológicos relacionados con la microalbuminuria en pacientes con diabetes mellitus de tipo 2 / Clinical and epidemiological aspects related to microalbuminuria in patients with type 2 diabetes mellitus

Se realizó un estudio observacional, descriptivo, de serie de casos, para determinar la presencia de microalbuminuria en pacientes con diabetes mellitus de tipo 2, dispensarizados en el consultorio médico No. 42 del Policlínico Docente José Martí Pérez de Santiago de Cuba, desde octubre de 2016 hasta igual mes de 2017. En la serie, el grupo etario de mayor connotación epidemiológica, relacionado con la microalbuminuria de rango elevado, resultó ser el de 60-64 años (86,7 por ciento). El tiempo de evolución de la diabetes estuvo estrechamente vinculado con la detección de microalbuminuria elevada; asimismo, los diferentes estadios de la enfermedad renal crónica guardaron relación con el tiempo de evolución de la enfermedad, es decir, el estadio 1 se correspondió con el inicio de la diabetes y los estadios 4 y 5 con los enfermos con más de 10 años de evolución. Se evidenció la importancia del estudio de la microalbuminuria en enfermos con pocos años de evolución de la enfermedad

An observational, descriptive and serial cases study, to determine the presence of microalbuminuria in 80 patients with type 2 diabetes mellitus, classified in the doctor's office No. 42 of José Martí Pérez Teaching Polyclinic was carried out in Santiago de Cuba, from October, 2016 to the same month in 2017. In the series, the 60-64 age group was the one with higher epidemiological connotation, related to the microalbuminuria of high range (86.7 percent). The course time of the diabetes was closely linked with the detection of high microalbuminuria; also, the different stages of the chronic renal disease bore no relation with the course time of the illness, that is to say, the stage 1 was in correspondence with the beginning of the diabetes and the stages 4 and 5 with the patients with more than 10 years of clinical course. The importance of studying the microalbuminuria was evidenced in patients with few years of the disease course